全文获取类型
收费全文 | 2314篇 |
免费 | 184篇 |
国内免费 | 123篇 |
学科分类
工业技术 | 2621篇 |
出版年
2024年 | 21篇 |
2023年 | 105篇 |
2022年 | 233篇 |
2021年 | 307篇 |
2020年 | 108篇 |
2019年 | 64篇 |
2018年 | 67篇 |
2017年 | 85篇 |
2016年 | 95篇 |
2015年 | 87篇 |
2014年 | 108篇 |
2013年 | 135篇 |
2012年 | 140篇 |
2011年 | 141篇 |
2010年 | 93篇 |
2009年 | 96篇 |
2008年 | 86篇 |
2007年 | 98篇 |
2006年 | 93篇 |
2005年 | 96篇 |
2004年 | 73篇 |
2003年 | 44篇 |
2002年 | 53篇 |
2001年 | 34篇 |
2000年 | 34篇 |
1999年 | 25篇 |
1998年 | 16篇 |
1997年 | 10篇 |
1996年 | 9篇 |
1995年 | 19篇 |
1994年 | 7篇 |
1993年 | 8篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 4篇 |
1989年 | 3篇 |
1988年 | 3篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 5篇 |
1982年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有2621条查询结果,搜索用时 0 毫秒
1.
1Introduction Reconstructivesurgeryisoneofthehottestre searchedsubjectsthatdealingwithbonedefects.Thetra ditionalmethodisimplantationoffreshautograftbonebe causeofitsnon immunoreactiveproperty.Butautologousbonewasnotabundantinsomecases.Sowefoundbeta trica… 相似文献
2.
杨加峰 《武汉理工大学学报(材料科学英文版)》2005,20(Z1)
1Introduction HA(hydroxyapatite)wasakindofbioactiveceram ics,whichhadexcellentbiocompatibilityandtissueaffin ityinthatitscomponentsweresimilartothoseofhuman bone[1].Soitwasthebestknownhumanbonesubstitute,andunprecedentedeffecthadbeenharvestedinrecenttwo d… 相似文献
3.
G.O. Phillips S. Al-Assaf A. du Plessis 《Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms》2007,265(1):390-393
Using a mediating alkyne gas during the radiation treatment prevents the degradation of natural and synthetic polysaccharides and proteins. The product has higher viscosity and is more elastic than the original material and, therefore, gives enhanced functionality. Protein, within demineralised bone, too can be modified to give enhanced osteoinductive capacity after transplantation. Thus new functionalities can be achieved from the new products produced in food and medical products. 相似文献
4.
S. Abiraman H. K. Varma T. V. Kumari P. R. Umashankar Annie John 《Bulletin of Materials Science》2002,25(5):419-429
This study investigates quantitatively and qualitatively the sol-gel derived bioactive glass-ceramic system (BGS)—apatite-wollastonite
(AW) type granules in the size range of 0.5–1 mm, as an effective graft material for bone augmentation and restoration. Scanning
electron micrographs (SEM) of the sintered granules revealed the rough material surface with micropores in the range 10–30
μm. X-ray diffraction (XRD) pattern of the granules revealed the presence of crystalline phases of the hydroxyapatite and
wollastonite, and the functional groups of the silicate and phosphates were identified by Fourier transform infrared spectroscopy
(FT-IR). Thein vitro cell culture studies with L929 mouse fibroblast cell line showed very few cells adhered on the BGS disc after 24 h. This
could be due to the highly reactive surface of the disc concomitant with the crystallization but not due to the cytotoxicity
of the material, since the cellular viability (MTT assay) with the material was 80‰ Cytotoxicity and cytocompatibility studies
proved that the material was non-toxic and biocompatible. After 12 weeks of implantation of the BGS granules in the tibia
bone of New Zealand white rabbits, the granules were found to be well osteointegrated, as observed in the radiographs. Angiogram
with barium sulphate and Indian ink after 12 weeks showed the presence of microcapillaries in the vicinity of the implant
site implicating high vascularity. Gross observation of the implant site did not show any inflammation or necrosis. SEM of
the implanted site after 24 weeks revealed good osteointegration of the material with the newly formed bone and host bone.
New bone was also observed within the material, which was degrading. Histological evaluation of the bone healing with the
BGS granules in the tibial defect at all time intervals was without inflammation or fibrous tissue encapsulation. After 2
weeks the new bone was observed as a trabeculae network around the granules, and by 6 weeks the defect was completely closed
with immature woven bone. By 12 weeks mature woven bone was observed, and new immature woven bone was seen within the cracks
of the granules. After 24 weeks the defect was completely healed with lamellar bone and the size of the granules decreased.
Histomorphometrically the area percentage of new bone formed was 67.77% after 12 weeks and 63.37% after 24 weeks. Less bone
formation after 24 weeks was due to an increased implant surface area contributed by the material degradation and active bone
remodeling. The osteostimulative and osteoconductive potential of the BGS granules was established by tetracycline labelling
of the mineralizing areas by 2 and 6 weeks. This sol-gel derived BGS granules proved to be bioactive and resorbable which
in turn encouraged active bone formation. 相似文献
5.
H. de Groot 《Materialwissenschaft und Werkstofftechnik》2007,38(12):965-968
Ischemia‐reperfusion injury of the bone occurs due to traumatic and non‐traumatic alterations affecting blood supply to the bone. It is likely to occur also upon insertion of an implant. Ischemia‐reperfusion injury of the bone has been studied by interruption of blood supply in situ, in limb replantation/transplantation models, in revascularized bone grafts and non‐vascularized bone fragments, as well as in isolated cultured cells. All cells of the bone are affected, including osteoblasts, osteocytes, osteoclasts, chondrocytes, and bone marrow cells. Critical ischemia times for induction of bone cell death, either in the ischemic period or following reperfusion, are in the range of 3 to 7 h. These critical ischemia times are significantly increased by decreasing the temperature from 37 °C to 0–4 °C. Anoxia is the most likely trigger of cell injury in the ischemic phase. In the reperfusion phase, reactive oxygen species are decisively involved in the injurious process. In general, however, the available information on the mechanism of ischemia‐reperfusion injury of the bone is relatively sparse. On the other hand, there are clear similarities to the mechanisms of ischemia‐reperfusion injury known from other organs, and there is a clear potential for protection against ischemia‐reperfusion injury of the bone. 相似文献
6.
A method has been developed, using a silicon-rubber-based sealant, which allows 2–3-mm-thick specimens to be maintained in a protected fluid environment for a number of months, without risk of dehydration. Following this, the specimen can be retrieved, stained, embedded and sectioned further. For example, 2-mm-thick sections of fixed unstained bone are easily examined by means of epi-illuminated polarized light and fluorescence microscopies using either conventional or confocal optics. The method could easily be extended to other tissues, for example brain tissue. 相似文献
7.
Ineke D.C. Jansen Socrates E. Papapoulos Nathalie Bravenboer Teun J. de Vries Natasha M. Appelman-Dijkstra 《International journal of molecular sciences》2021,22(4)
Pycnodysostosis, a rare autosomal recessive skeletal dysplasia, is caused by a deficiency of cathepsin K. Patients have impaired bone resorption in the presence of normal or increased numbers of multinucleated, but dysfunctional, osteoclasts. Cathepsin K degrades collagen type I and generates N-telopeptide (NTX) and the C-telopeptide (CTX) that can be quantified. Levels of these telopeptides are increased in lactating women and are associated with increased bone resorption. Nothing is known about the consequences of cathepsin K deficiency in lactating women. Here we present for the first time normalized blood and CTX measurements in a patient with pycnodysostosis, exclusively related to the lactation period. In vitro studies using osteoclasts derived from blood monocytes during lactation and after weaning further show consistent bone resorption before and after lactation. Increased expression of cathepsins L and S in osteoclasts derived from the lactating patient suggests that other proteinases could compensate for the lack of cathepsin K during the lactation period of pycnodysostosis patients. 相似文献
8.
Metastasis to the bone is a common feature of many cancers including those of the breast, prostate, lung, thyroid and kidney. Once tumors metastasize to the bone, they are essentially incurable. Bone metastasis is a complex process involving not only intravasation of tumor cells from the primary tumor into circulation, but extravasation from circulation into the bone where they meet an environment that is generally suppressive of their growth. The bone microenvironment can inhibit the growth of disseminated tumor cells (DTC) by inducing dormancy of the DTC directly and later on following formation of a micrometastatic tumour mass by inhibiting metastatic processes including angiogenesis, bone remodeling and immunosuppressive cell functions. In this review we will highlight some of the mechanisms mediating DTC dormancy and the complex relationships which occur between tumor cells and bone resident cells in the bone metastatic microenvironment. These inter-cellular interactions may be important targets to consider for development of novel effective therapies for the prevention or treatment of bone metastases. 相似文献
9.
Patricia A. Miguez Stephen A. Tuin Adam G. Robinson Joyce Belcher Prapaporn Jongwattanapisan Kimberly Perley Vinicius de Paiva Gon«alves Arash Hanifi Nancy Pleshko Elisabeth R. Barton 《International journal of molecular sciences》2021,22(6)
This study evaluated the direct effect of a phytochemical, hesperidin, on pre-osteoblast cell function as well as osteogenesis and collagen matrix quality, as there is little known about hesperidin’s influence in mineralized tissue formation and regeneration. Hesperidin was added to a culture of MC3T3-E1 cells at various concentrations. Cell proliferation, viability, osteogenic gene expression and deposited collagen matrix analyses were performed. Treatment with hesperidin showed significant upregulation of osteogenic markers, particularly with lower doses. Mature and compact collagen fibrils in hesperidin-treated cultures were observed by picrosirius red staining (PSR), although a thinner matrix layer was present for the higher dose of hesperidin compared to osteogenic media alone. Fourier-transform infrared spectroscopy indicated a better mineral-to-matrix ratio and matrix distribution in cultures exposed to hesperidin and confirmed less collagen deposited with the 100-µM dose of hesperidin. In vivo, hesperidin combined with a suboptimal dose of bone morphogenetic protein 2 (BMP2) (dose unable to promote healing of a rat mandible critical-sized bone defect) in a collagenous scaffold promoted a well-controlled (not ectopic) pattern of bone formation as compared to a large dose of BMP2 (previously defined as optimal in healing the critical-sized defect, although of ectopic nature). PSR staining of newly formed bone demonstrated that hesperidin can promote maturation of bone organic matrix. Our findings show, for the first time, that hesperidin has a modulatory role in mineralized tissue formation via not only osteoblast cell differentiation but also matrix organization and matrix-to-mineral ratio and could be a potential adjunct in regenerative bone therapies. 相似文献
10.
Annica Prhl Milijana Batinic Said Alkildani Michael Hahn Milena Radenkovic Stevo Najman Ole Jung Mike Barbeck 《International journal of molecular sciences》2021,22(9)
The present in vivo study analyses both the inflammatory tissue reactions and the bone healing capacity of a newly developed bone substitute material (BSM) based on xenogeneic bone substitute granules combined with hyaluronate (HY) as a water-binding molecule. The results of the hyaluronate containing bone substitute material (BSM) were compared to a control xenogeneic BSM of the same chemical composition and a sham operation group up to 16 weeks post implantationem. A major focus of the study was to analyze the residual hyaluronate and its effects on the material-dependent healing behavior and the inflammatory tissue responses. The study included 63 male Wistar rats using the calvaria implantation model for 2, 8, and 16 weeks post implantationem. Established and Good Laboratory Practice (GLP)-conforming histological, histopathological, and histomorphometrical analysis methods were conducted. The results showed that the new hyaluronate containing BSM was gradually integrated within newly formed bone up to the end of the study that ended in a condition of complete bone defect healing. Thereby, no differences to the healing capacity of the control BSM were found. However, the bone formation in both groups was continuously significantly higher compared to the sham operation group. Additionally, no differences in the (inflammatory) tissue response that was analyzed via qualitative and (semi-) quantitative methods were found. Interestingly, no differences were found between the numbers of pro- and anti-inflammatory macrophages between the three study groups over the entire course of the study. No signs of the HY as a water-binding part of the BSM were histologically detectable at any of the study time points, altogether the results of the present study show that HY allows for an optimal material-associated bone tissue healing comparable to the control xenogeneic BSM. The added HY seems to be degraded within a very short time period of less than 2 weeks so that the remaining BSM granules allow for a gradual osteoconductive bone regeneration. Additionally, no differences between the inflammatory tissue reactions in both material groups and the sham operation group were found. Thus, the new hyaluronate containing xenogeneic BSM and also the control BSM have been shown to be fully biocompatible without any differences regarding bone regeneration. 相似文献